The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...

WASHINGTON (AP) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the ...

AstraZeneca's deal follows a similar agreement Pfizer announced late last month. Advocates have generally praised the administration's efforts to cut drug prices, though some have expressed concerns ...

AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the ...